Genmab A/S Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 14.94 M | $311.70 M | -1.33% | 23.02% |
BLACKROCK, INC. | 02/07/2025 | 4.20 M | $87.62 M | -9.06% | 6.47% |
CITADEL ADVISORS LLC | 02/14/2025 | 3.09 M | $64.53 M | 137.88% | 4.77% |
ORBIS ALLAN GRAY LTD | 02/14/2025 | 2.82 M | $58.76 M | 67.91% | 4.34% |
MORGAN STANLEY | 02/14/2025 | 2.81 M | $58.56 M | 71.05% | 4.32% |
CAPITAL INTERNATIONAL INVESTORS | 02/13/2025 | 2.57 M | $53.40 M | -41.86% | 3.96% |
HARDING LOEVNER LP | 02/14/2025 | 2.24 M | $46.82 M | -26.85% | 3.46% |
DEEP TRACK CAPITAL, LP | 02/14/2025 | 2.00 M | $41.74 M | 100.00% | 3.08% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.93 M | $40.20 M | 7.82% | 2.97% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 1.71 M | $35.61 M | 122.21% | 2.63% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 1.65 M | $34.51 M | 168.82% | 2.55% |
FIRST TRUST ADVISORS LP | 02/13/2025 | 1.64 M | $34.32 M | 18.04% | 2.53% |
BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 02/12/2025 | 1.62 M | $33.80 M | 100.00% | 2.50% |
UBS GROUP AG | 02/14/2025 | 1.44 M | $30.07 M | 2,283.65% | 2.22% |
MARSHALL WACE, LLP | 02/13/2025 | 1.12 M | $23.42 M | 162.19% | 1.73% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 1.11 M | $23.17 M | 102.43% | 1.71% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 927,752 | $19.36 M | 64.25% | 1.43% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 773,104 | $16.13 M | -6.31% | 1.19% |
ENVESTNET ASSET MANAGEMENT INC | 02/13/2025 | 723,781 | $15.11 M | -30.64% | 1.12% |
NORTHERN TRUST CORP | 02/14/2025 | 599,381 | $12.51 M | 18.80% | 0.92% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 592,250 | $12.36 M | 100.00% | 0.91% |
FMR LLC | 02/13/2025 | 540,553 | $11.28 M | 94.31% | 0.83% |
HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 540,000 | $11.27 M | 103.77% | 0.83% |
RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 510,784 | $10.66 M | 18,959.10% | 0.79% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 474,858 | $9.91 M | -54.97% | 0.73% |
JPMORGAN CHASE & CO | 02/12/2025 | 407,613 | $8.51 M | 3,049.29% | 0.63% |
TREXQUANT INVESTMENT LP | 02/12/2025 | 379,936 | $7.93 M | 495.07% | 0.59% |
ROYAL BANK OF CANADA | 02/14/2025 | 324,002 | $6.76 M | -59.39% | 0.50% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 320,575 | $6.69 M | -19.27% | 0.49% |
BRIDGER MANAGEMENT, LLC | 02/14/2025 | 291,500 | $6.08 M | 100.00% | 0.45% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 283,111 | $5.91 M | -59.58% | 0.44% |
JANE STREET GROUP, LLC | 02/14/2025 | 263,403 | $5.50 M | 100.00% | 0.41% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 236,836 | $4.94 M | -24.47% | 0.37% |
DDD PARTNERS, LLC | 01/31/2025 | 226,074 | $4.72 M | -61.23% | 0.35% |
HARDMAN JOHNSTON GLOBAL ADVISORS LLC | 02/04/2025 | 214,472 | $4.48 M | -5.92% | 0.33% |
OPPENHEIMER ASSET MANAGEMENT INC. | 02/05/2025 | 207,107 | $4.32 M | -10.82% | 0.32% |
NATIXIS ADVISORS, L.P. | 02/10/2025 | 205,769 | $4.29 M | -0.38% | 0.32% |
01/30/2025 | 176,898 | $3.69 M | 100.00% | 0.27% | |
FOLKETRYGDFONDET | 02/07/2025 | 170,385 | $3.56 M | 0.00% | 0.26% |
AIMZ INVESTMENT ADVISORS, LLC | 02/05/2025 | 168,905 | $3.53 M | 100.00% | 0.26% |
US BANCORP \DE\ | 02/05/2025 | 164,548 | $3.43 M | -4.15% | 0.25% |
INGALLS & SNYDER LLC | 01/29/2025 | 136,059 | $2.84 M | -37.73% | 0.21% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 128,100 | $2.67 M | 100.00% | 0.20% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 122,373 | $2.55 M | 100.00% | 0.19% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 118,002 | $2.46 M | 100.00% | 0.18% |
SQUAREPOINT OPS LLC | 02/14/2025 | 117,507 | $2.45 M | 1,235.00% | 0.18% |
OLD MISSION CAPITAL LLC | 02/12/2025 | 111,601 | $2.33 M | 100.00% | 0.17% |
VERITION FUND MANAGEMENT LLC | 02/14/2025 | 108,419 | $2.26 M | 272.91% | 0.17% |
STIFEL FINANCIAL CORP | 02/13/2025 | 108,175 | $2.26 M | -35.99% | 0.17% |
CREATIVE PLANNING | 02/14/2025 | 106,828 | $2.23 M | 125.27% | 0.16% |
Genmab A/S institutional Ownership - FAQ's
During the previous two years, 292 institutional investors and hedge funds held shares of Genmab A/S. The most heavily invested institutionals were:
ALLIANCEBERNSTEIN L.P.: 14.94 M
BlackRock, Inc.: 4.2 M
CITADEL ADVISORS LLC: 3.09 M
Orbis Allan Gray Ltd: 2.82 M
MORGAN STANLEY: 2.81 M
Capital International Investors: 2.57 M
93.68% of Genmab A/S stock is owned by institutional investors.
Institutional investors have bought a total of 71.17 M shares in the last 24 months. This purchase volume represents approximately $1.28 B in transactions.